Inventor · disambiguated record
Mahmood Ahmed
Also filed as: AHMED MAHMOOD
7 granted patents·9 pending applications·81 citations·filing 2002–2020
87Inventor score
Top patents by PatentIndex Score
16 records- 0192US7601837B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2008·Granted Oct 13, 2009·15 cites·3 claims
- 0290US7799774B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2009·Granted Sep 21, 2010·11 cites·15 claims
- 0389US7977337B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2010·Granted Jul 12, 2011·11 cites·10 claims
- 0489US7452888B2Quinoline derivatives and their use as 5-ht6 ligandsGLAXO GROUP LTD·Filed 2003·Granted Nov 18, 2008·23 cites·11 claims
- 0588US8236947B2Quinoline derivatives and their use as 5-HT6 ligandsAHMED MAHMOOD·Filed 2011·Granted Aug 7, 2012·11 cites·18 claims
- 0677US8324254B2Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonistsAHMED MAHMOOD·Filed 2008·Granted Dec 4, 2012·5 cites·7 claims
- 0777US8101775B2Indole derivatives as S1P1 ReceptorAHMED MAHMOOD·Filed 2007·Granted Jan 24, 2012·5 cites·4 claims
- 0845US2007232657A1Novel compoundsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 0944US2009012056A1Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 ReceptorGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 1044US2023064920A1Process of preparing arachidonoylethanolamine analoguesTRAVECTA THERAPEUTICS PTE LTD·Filed 2020·Application pending·0 cites
- 1144US2010048639A1Oxadiazole derivates as s1p1 receptor agonistsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 1242US2005176759A17-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disordersFiled 2002·Application pending·0 cites
- 1342US2005090496A1Sulphonyl compounds with 5-ht6 receptor affinityFiled 2003·Application pending·0 cites
- 1441US2008318933A15-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns DisordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 1540US2007191345A13-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 1639US2022112225A1Anandamide compoundsTRAVECTA THERAPEUTICS PTE LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mahmood Ahmed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →